Answers are grounded in this paper and cite their sources.
Prospective observational study shows improved self-efficacy and reduced readmissions in lymphoma patients after CAR-T therapy, indicating effective care transition.
251 Background: Sequential CAR-T therapy for relapsed/refractory lymphoma imposes severe physiological and psychological burdens, exacerbated by a fragmented care continuum. Standard nursing care prioritizes acute inpatient toxicity, creating gaps in post-discharge patient empowerment. We evaluated a structured, nurse-led transitional care model (TCM) designed to enhance self-efficacy, alleviate distress, and ensure continuous care from the inpatient setting to the home. Methods: A prospective observational study (March 2024–November 2025) enrolled 27 lymphoma patients receiving a second or subsequent CAR-T infusion. The TCM featured four pillars: 1) Pre-infusion empowerment focusing on symptom self-monitoring; 2) Inpatient symptom cluster surveillance (tracking fatigue, low-grade fever, cognitive fog) for early CRS/ICANS detection; 3) Guided discharge utilizing teach-back validation; and 4) 90-day post-discharge digital health navigation via telehealth. Primary endpoints were baseline to Day +90 changes in self-efficacy (General Self-Efficacy Scale) and psychological distress (HADS). The secondary endpoint was the 30-day unplanned readmission rate. Results: The TCM was successfully implemented in all 27 patients. Mean GSES scores improved significantly from 25.4 at baseline to 33.1 at Day +90 (p<0.001). Psychological burden was notably reduced: mean HADS-Anxiety decreased from 9.8 to 6.2 (p<0.01), and HADS-Depression from 8.5 to 5.9 (p<0.05). The 30-day unplanned readmission rate for toxicity/infection was 7.4% (n=2), a profound reduction compared to the 25% institutional historical control (p<0.05). Early symptom surveillance triggered preemptive clinical interventions in 55.6% of cases (n=15), effectively preventing any progression to grade ≥3 ICANS. Conclusions: A structured, nurse-led TCM significantly improves patient self-efficacy, alleviates psychological distress, and reduces costly unplanned readmissions in sequential CAR-T therapy. By shifting clinical focus from reactive acute management to proactive patient navigation, this model provides a highly scalable, evidence-based framework to optimize holistic outcomes in vulnerable oncology populations.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: